Cargando…
Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors
Preliminary data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with higher mortality among cancer patients, particularly in those on systemic therapy. It is unclear whether this applies to patients receiving immune checkpoint inhibitors (ICIs). In...
Autores principales: | Szabados, Bernadett, Abu-Ghanem, Yasmin, Grant, Michael, Choy, Julia, Bex, Axel, Powles, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association of Urology. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247982/ https://www.ncbi.nlm.nih.gov/pubmed/32534910 http://dx.doi.org/10.1016/j.eururo.2020.05.024 |
Ejemplares similares
-
Cytoreductive nephrectomy in the current treatment
algorithm
por: Kuusk, Teele, et al.
Publicado: (2019) -
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment
por: Meerveld-Eggink, Aafke, et al.
Publicado: (2022) -
Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?
por: Mumm, Jan-Niclas, et al.
Publicado: (2020) -
The efficacy of immune checkpoint inhibitors in thoracic malignancies
por: Remon, Jordi, et al.
Publicado: (2021) -
Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients
por: Abrishami, Alireza, et al.
Publicado: (2020)